Cervical Cancer

Harvey W. Kaufman, MD, on Cotesting for Cervical Cancer
August 05, 2020

The researcher from Quest Diagnostics spoke about a recent study which confirmed the benefit of using liquid-based cytology in cotesting for cervical cancer.

ACS Updates Guidelines for Cervical Cancer Screening
August 04, 2020

The new guidelines suggest the need to phase out cotesting and cytology, shifting towards primary HPV testing starting at age 25 years.

Tisotumab Vedotin Sees Positive Topline Results in the Phase 2 InnovaTV 204 Trial
June 30, 2020

The trial is evaluating tisotumab vedotin administered every 3 weeks for the treatment of patients who have relapsed or progressed on or after prior treatment for recurrent or metastatic cervical cancer.